Ergocalciferol in Chronic Kidney Disease
Completed
- Conditions
- Chronic Kidney Disease
- Registration Number
- NCT00411294
- Lead Sponsor
- Saint Louis VA Medical Center
- Brief Summary
To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Patient with CKD stage 3 or 4 whose 25-hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels >70 pg/ml.
Exclusion Criteria
- Patients who are on any form of active vitamin treatment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Saint Louis VA Medical Center
🇺🇸Saint Louis, Missouri, United States